메뉴 건너뛰기




Volumn 69, Issue 4, 2001, Pages 281-286

New advances in the treatment of sickle cell disease: Focus on perioperative significance

(1)  Dix, H M a  

a NONE

Author keywords

Anesthesia; Pain; Sickle cell anemia

Indexed keywords

ANALGESIC AGENT; BUTORPHANOL; DROXEA; FLOCOR; FRUCTOSE 1,6 BISPHOSPHATE; HYDROXYUREA; KETOROLAC; MORPHINE; NALBUPHINE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORPETHIDINE; OPIATE AGONIST; OPIATE ANTAGONIST; PETHIDINE; POLOXAMER;

EID: 0034886717     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (16)

References (27)
  • 3
    • 0028850589 scopus 로고
    • Pathophysiology and management of sickle cell pain crisis. Report of a Meeting of Physicians and Scientists, University of Texas Health Science Center at Houston, Texas
    • (1995) Lancet , vol.346 , pp. 1408-1411
  • 7
  • 12
    • 0026748439 scopus 로고
    • Survey of pain management therapy provided for children with sickle cell disease
    • (1992) Clin Pediatr , vol.31 , pp. 211-214
    • Pegelow, C.H.1
  • 15
    • 0029025475 scopus 로고
    • Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
    • Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
    • (1995) N Engl J Med , vol.332 , pp. 1317-1322
    • Charache, S.1    Terrin, M.2    Moore, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.